| Year |
Citation |
Score |
| 2018 |
Zhou Y, Alimohamadi S, Wang L, Liu Z, Wall JB, Yin C, Liu J, Qian L. A Loss of Function Screen of Epigenetic Modifiers and Splicing Factors during Early Stage of Cardiac Reprogramming. Stem Cells International. 2018: 3814747. PMID 29743891 DOI: 10.1155/2018/3814747 |
0.32 |
|
| 2017 |
Liu Z, Wang L, Welch JD, Ma H, Zhou Y, Vaseghi HR, Yu S, Wall JB, Alimohamadi S, Zheng M, Yin C, Shen W, Prins JF, Liu J, Qian L. Single-cell transcriptomics reconstructs fate conversion from fibroblast to cardiomyocyte. Nature. PMID 29072293 DOI: 10.1038/Nature24454 |
0.325 |
|
| 2016 |
Liu Z, Chen O, Zheng M, Wang L, Zhou Y, Yin C, Liu J, Qian L. Re-patterning of H3K27me3, H3K4me3 and DNA methylation during fibroblast conversion into induced cardiomyocytes. Stem Cell Research. 16: 507-518. PMID 26957038 DOI: 10.1016/J.Scr.2016.02.037 |
0.32 |
|
| 2016 |
Zhou Y, Wang L, Vaseghi HR, Liu Z, Lu R, Alimohamadi S, Yin C, Fu JD, Wang GG, Liu J, Qian L. Bmi1 Is a Key Epigenetic Barrier to Direct Cardiac Reprogramming. Cell Stem Cell. 18: 382-395. PMID 26942853 DOI: 10.1016/J.Stem.2016.02.003 |
0.3 |
|
| 2015 |
Wang L, Liu Z, Yin C, Asfour H, Chen O, Li Y, Bursac N, Liu J, Qian L. Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming. Circulation Research. 116: 237-44. PMID 25416133 DOI: 10.1161/Circresaha.116.305547 |
0.31 |
|
| 2013 |
Park IW, Ndjomou J, Wen Y, Liu Z, Ridgway ND, Kao CC, He JJ. Inhibition of HCV replication by oxysterol-binding protein-related protein 4 (ORP4) through interaction with HCV NS5B and alteration of lipid droplet formation. Plos One. 8: e75648. PMID 24069433 DOI: 10.1371/Journal.Pone.0075648 |
0.301 |
|
| Show low-probability matches. |